MedTrace Logo

Radio Frequency (RF) Device for Reduction in Size of Localized Areas of the Body

NCT00953160 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2023-09-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the Cutera radio frequency (RF) device for the new indication of reduction in size of localized areas of the body.

Conditions

  • Cellulite

Interventions

DEVICE

Cutera Radio Frequency Device

Up to three treatments, one pass, dosage range of 15-60 kJ.

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Principal Investigators

  • Brian Biesman, MD

  • Jacqueline Calkin, MD

  • Stephen Ronan, MD

  • Scott Kramer, MD

  • Adele Makow, MD

  • Barry DiBernardo, MD

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00953160 on ClinicalTrials.gov